Eurofins-Cerep SA (ALECR) - Total Liabilities
Based on the latest financial reports, Eurofins-Cerep SA (ALECR) has total liabilities worth €12.43 Million EUR (≈ $14.53 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Eurofins-Cerep SA's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Eurofins-Cerep SA - Total Liabilities Trend (2000–2025)
This chart illustrates how Eurofins-Cerep SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Eurofins-Cerep SA.
Eurofins-Cerep SA Competitors by Total Liabilities
The table below lists competitors of Eurofins-Cerep SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vizsla Copper Corp
V:VCU
|
Canada | CA$2.09 Million |
|
IX Acquisition Corp
NASDAQ:IXAQ
|
USA | $13.70 Million |
|
GrandTech C.G. Systems
TWO:6123
|
Taiwan | NT$1.90 Billion |
|
Demco Public Company Limited
BK:DEMCO
|
Thailand | ฿2.35 Billion |
|
Shinyoung Waco
KO:005800
|
Korea | ₩39.27 Billion |
|
Vow ASA
OL:VOW
|
Norway | Nkr849.80 Million |
|
Empery Digital Inc.
NASDAQ:EMPD
|
USA | $51.74 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Eurofins-Cerep SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ALECR equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eurofins-Cerep SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eurofins-Cerep SA (2000–2025)
The table below shows the annual total liabilities of Eurofins-Cerep SA from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €12.43 Million ≈ $14.53 Million |
+0.85% |
| 2024-12-31 | €12.32 Million ≈ $14.41 Million |
-15.79% |
| 2023-12-31 | €14.63 Million ≈ $17.11 Million |
+3.65% |
| 2022-12-31 | €14.12 Million ≈ $16.51 Million |
-1.63% |
| 2021-12-31 | €14.35 Million ≈ $16.78 Million |
+31.08% |
| 2020-12-31 | €10.95 Million ≈ $12.80 Million |
+5.12% |
| 2019-12-31 | €10.42 Million ≈ $12.18 Million |
+3.20% |
| 2018-12-31 | €10.09 Million ≈ $11.80 Million |
+13.76% |
| 2017-12-31 | €8.87 Million ≈ $10.37 Million |
+4.56% |
| 2016-12-31 | €8.49 Million ≈ $9.92 Million |
-16.91% |
| 2015-12-31 | €10.21 Million ≈ $11.94 Million |
+4.88% |
| 2014-12-31 | €9.74 Million ≈ $11.38 Million |
-33.03% |
| 2013-12-31 | €14.54 Million ≈ $17.00 Million |
-11.07% |
| 2012-12-31 | €16.35 Million ≈ $19.11 Million |
-14.65% |
| 2011-12-31 | €19.16 Million ≈ $22.39 Million |
-13.96% |
| 2010-12-31 | €22.26 Million ≈ $26.03 Million |
-12.37% |
| 2009-12-31 | €25.41 Million ≈ $29.70 Million |
-24.02% |
| 2008-12-31 | €33.44 Million ≈ $39.09 Million |
-13.86% |
| 2007-12-31 | €38.81 Million ≈ $45.38 Million |
-37.64% |
| 2006-12-31 | €62.25 Million ≈ $72.77 Million |
+18.53% |
| 2005-12-31 | €52.52 Million ≈ $61.40 Million |
+65.01% |
| 2004-12-31 | €31.83 Million ≈ $37.21 Million |
+47.48% |
| 2003-12-31 | €21.58 Million ≈ $25.23 Million |
+17.33% |
| 2002-12-31 | €18.39 Million ≈ $21.50 Million |
+24.89% |
| 2001-12-31 | €14.73 Million ≈ $17.22 Million |
+25.88% |
| 2000-12-31 | €11.70 Million ≈ $13.68 Million |
-- |
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was foun… Read more